Our results, summarized in Table 1, show that the role of Ankrd2 in osteosarcoma progression is heterogeneous and, in some cases, particular to the cell line tested, suggesting that cell line-specific factors might contribute to the overall Ankrd2-related effects. The gene discussed is ANKRD2; the disease is osteosarcoma.